(S)-1-(5-chloro-2-((3,5-difluorophenyl)amino)pyrimidin-4-yl)-N-(3-(dimethylcarbamoyl)-4-(4-methylpiperazin-1-yl)phenyl)pyrrolidine-2-carboxamide

ID: ALA4853913

PubChem CID: 164614025

Max Phase: Preclinical

Molecular Formula: C29H33ClF2N8O2

Molecular Weight: 599.09

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CN1CCN(c2ccc(NC(=O)[C@@H]3CCCN3c3nc(Nc4cc(F)cc(F)c4)ncc3Cl)cc2C(=O)N(C)C)CC1

Standard InChI:  InChI=1S/C29H33ClF2N8O2/c1-37(2)28(42)22-16-20(6-7-24(22)39-11-9-38(3)10-12-39)34-27(41)25-5-4-8-40(25)26-23(30)17-33-29(36-26)35-21-14-18(31)13-19(32)15-21/h6-7,13-17,25H,4-5,8-12H2,1-3H3,(H,34,41)(H,33,35,36)/t25-/m0/s1

Standard InChI Key:  LMJSHYFDSZRXBO-VWLOTQADSA-N

Molfile:  

 
     RDKit          2D

 42 46  0  0  0  0  0  0  0  0999 V2000
    7.4381  -12.9447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2412  -13.1153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1002  -11.7963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4365  -11.8626    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.9917  -10.5101    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7942  -10.9002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3492  -12.1306    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6634  -12.1347    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.2113  -10.9055    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.8245  -11.3139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2177  -11.7243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0391  -10.1871    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.7970  -11.7265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4871  -12.0865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6601  -11.2835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0963  -12.6371    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6488  -12.4045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0502  -10.7367    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.6560  -10.4424    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0830  -10.4910    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6386  -11.7231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3741  -11.7270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0806   -9.6702    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.5080  -12.1336    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9253  -12.1318    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6377  -10.9014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4350  -11.0301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0848  -12.1357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0455  -11.5730    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8773  -12.3809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2702  -10.9931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3753  -10.9038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9176  -10.4902    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4868  -12.9220    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.7756  -10.2561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3816   -9.9673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3209  -13.7167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9264  -14.2569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7014  -14.0035    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.8674  -13.2046    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2583  -12.6591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3105  -14.5483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 24 11  1  0
 22 28  1  0
 16 30  2  0
 14 16  1  0
 29 27  2  0
 26 12  1  0
 27 15  1  0
 13 24  1  0
 30 29  1  0
 10  4  2  0
 20 32  1  0
 20 23  1  0
 25 21  1  0
 22  8  1  0
 28 13  2  0
 10  5  1  0
 31 18  1  0
 26 33  1  0
 21 26  2  0
  3 31  1  6
  3  7  1  0
 11 25  2  0
 31 19  2  0
  6 20  2  0
 32 22  2  0
 17  3  1  0
  1  2  1  0
 21  7  1  0
 13  6  1  0
  7  1  1  0
  2 17  1  0
 18 15  1  0
  9 11  1  0
 29 10  1  0
 15 14  2  0
 33  9  2  0
 30 34  1  0
  5 35  1  0
  5 36  1  0
 34 37  1  0
 34 41  1  0
 37 38  1  0
 38 39  1  0
 39 40  1  0
 40 41  1  0
 39 42  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4853913

    ---

Associated Targets(Human)

KM12 (47707 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H2228 (1030 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KARPAS-299 (888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NTRK1 Tclin Nerve growth factor receptor Trk-A (7922 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALK Tclin ALK tyrosine kinase receptor (7132 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 599.09Molecular Weight (Monoisotopic): 598.2383AlogP: 4.21#Rotatable Bonds: 7
Polar Surface Area: 96.94Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.06CX Basic pKa: 7.56CX LogP: 4.54CX LogD: 4.16
Aromatic Rings: 3Heavy Atoms: 42QED Weighted: 0.42Np Likeness Score: -1.83

References

1. Li T, Li C, Yang J, Guo M, Cao Z, Wang X, Jiang N, Zhai X..  (2021)  Discovery of novel 2-phenylamino-4-prolylpyrimidine derivatives as TRK/ALK dual inhibitors with promising antitumor effects.,  47  [PMID:34534734] [10.1016/j.bmc.2021.116396]

Source